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  A
cademic medicine occupies a 
spot in that rareﬁ  ed world in 
which one doesn’t have to do 
much to justify one’s existence. The 
best health care, the best research, the 
brightest minds on the planet circulate 
within academic medicine, together 
conspiring for the beneﬁ  t of patients 
and practitioners. 
    Correct? Perhaps not, as growing 
concern about a decline in the 
state of academic medicine around 
the world threatens this taken-for-
granted position [1–6]. In the past 
few years more and more critics have 
questioned the role and contribution 
of academic medicine—to society, to 
health-care systems, and to patients 
[7]. Who is academic medicine for? 
Why does it matter? What added value 
does it bring to disease prevention, 
health promotion, and the practice 
of health care? In order to engage 
our stakeholders—which include 
policymakers and the public—we 
need to demonstrate the beneﬁ  ts of 
academic medicine.
    Revitalising academic medicine 
matters because health costs and 
expectations are rising alongside 
growing concerns that academic 
medicine is failing to produce sufﬁ  cient 
gains for patients and funders. As 
others have argued, it is time for 
academic medicine to step up to the 
plate—to take leadership in redressing 
the gaps between bench and bedside 
medicine [8] and between the rich 
and the poor [9,10]. Taking leadership 
involves better preparation for future 
health-care demands in terms of 
attracting suitable and sufﬁ  cient human 
resources, and aligning priorities with 
global health needs. 
    That said, however, the case for 
why and how academic medicine 
ought to lead us forward must be 
evidence-based. At a time when there 
is increasing demand for academic 
medicine to be more accountable, 
we ﬁ  nd that the evidence base for its 
effectiveness is rather slim. Fortunately 
there is mounting interest in evaluating 
the impact of academic medicine 
across the traditional triad of medical 
research, education, and clinical care. 
    For example, in May of this year, the 
Academy of Medical Sciences released 
its report on the beneﬁ  ts of medical 
research to society (http:⁄⁄www.
acmedsci.ac.uk/images/project/
Medicalr.pdf). The Association 
of American Medical Colleges 
(http:⁄⁄www.aamc.org) has led work 
on improving the quality of medical 
education for the next generation of 
doctors and other health practitioners. 
And in a new systematic review in   PLoS 
Medicine  , John Ioannidis and colleagues 
examine the beneﬁ  ts of academic 
health care in terms of clinical 
outcomes [11]. 
  Evaluating  the  Evidence
    The International Campaign to 
Revitalise Academic Medicine 
(ICRAM), of which we are cofounders 
(among others), was launched 
in part to evaluate the evidence 
base of academic medicine [12]. 
John Ioannidis is a member of 
the working party of ICRAM and 
with his colleagues undertook a 
systematic review of studies evaluating 
the outcomes of care in teaching 
hospitals. Previous work has produced 
mixed ﬁ  ndings, and Ioannidis and 
colleagues’ work may be the ﬁ  rst 
attempt to systematically review the 
international literature. Their study 
is a valuable exercise; it not only 
provides a summary of the impact of 
academic versus nonacademic health 
care, but also identiﬁ  es deﬁ  ciencies in 
the current evidence base.
    Ioannidis and colleagues posed the 
question, Compared to non-academic 
health-care structures (hospitals, 
clinics, systems), do academic teaching 
hospitals produce better or worse 
patient outcomes? Their ﬁ  ndings 
suggest that, contrary to what many 
would expect (or hope), there is no 
evidence that teaching hospitals differ 
from nonacademic ones.
    The researchers reviewed 132 studies 
and found virtually no differences in 
mortality outcomes between teaching 
and nonteaching health-care structures 
across a range of diseases, even after 
adjusting for confounders. That is, they 
found no beneﬁ  ts in terms of mortality 
for patients receiving academic health 
care, but they also found no harms 
from receiving such care.
    The merits of this study lie ﬁ  rstly 
in its broad scope and systematic 
approach. Previous reviews have 
been unsystematic and none to our 
knowledge has shown the range and 
quality of searching of Ioannidis and 
colleagues’ study. Secondly, the study 
includes careful statistical adjustment 
for confounders. A chief concern in 
this area has always been the ability 
to account for factors such as case 
mix. After all, teaching hospitals tend 
to treat sicker patients and trainees 
need to learn by doing. In the other 
direction, teaching hospitals have 
more advanced technology and see 
a high volume of cases that is often 
associated with better outcomes [13]. 
Ioannidis and colleagues included 
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only adjusted estimates in their model, 
and speciﬁ  ed whether these were for 
volume, severity, or comorbidity. In a 
sensitivity analysis that looked at only 
those comparisons in which all three 
confounders were accounted for, still 
no signiﬁ  cant differences were found 
between teaching and nonteaching 
health care.
    As the authors point out, the 
literature is patchy and diverse, 
made up mostly of nonrandomised 
studies, and focused largely on 
“hard” patient outcomes such as 
mortality rather than “softer” patient 
reported outcomes such as distressing 
symptoms (pain), disability, and 
satisfaction. Randomising patients to 
receive academic versus nonacademic 
care (whether by provider, clinic, 
or system) is obviously a logistical 
challenge. Observational data remain 
far less ideal because they are prone 
to bias. 
    Similarly, it is unfortunate that the 
systematic review fails to shed light 
on outcomes for speciﬁ  c subgroups 
of patients. As part of new social 
accountability initiatives, some 
teaching hospitals focus especially 
on disadvantaged groups such as the 
indigent populations, and we do not 
yet know whether academic health-care 
settings generate better outcomes for 
these or other groups.
    Additional limitations emerge from 
the fact that the group of studies 
included in the systematic review is 
heterogeneous (though the authors 
account for this to the extent that 
they can), and undoubtedly residual 
confounding remains. In addition, 
almost three-quarters of studies 
included in the systematic review were 
conducted in the United States, and 
these are hardly generalizable to low- 
or middle-income countries. These US 
studies are even difﬁ  cult to apply to 
other industrialized countries’ health 
systems. 
  Engaging  Our  Stakeholders
    Ioannidis and colleagues’ work reveals 
important defects in the primary 
literature that limit our attempts to 
sell the story of academic medicine to 
our stakeholders. Most studies so far 
provide unadjusted data and deﬁ  ne a 
narrow set of outcomes, and very few 
have been conducted outside of the 
US. It appears few, if any, evaluations 
of academic medicine have been done 
in developing countries. While many 
of the challenges facing the future 
of academic medicine are shared by 
rich and poor countries [14], there 
are unique features of developing 
economies that merit special attention. 
Ioannidis and colleagues’ systematic 
review takes stock of the existing 
evidence regarding which aspects of 
academic health care work and which 
do not, and for whom, and paints a 
small picture. Clearly, in an era of 
changing expectations and demands 
for accountability, the systematic review 
signals the need for better and broader 
research methods, both quantitative 
and qualitative. 
    Ioannidis and colleagues’ study is an 
important step forward, and should be 
a call to arms for us all to work together 
to develop an evidence base on the 
outcomes of academic medicine.   
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